APW
STIM icon

Allied Private Wealth’s Neuronetics STIM Stock Holding History

Allied Private Wealth’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$723 Buy
+470
New +$684 ﹤0.01% 832

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Allied Private Wealth's STIM Position: Q2 2026 in Review

Allied Private Wealth opened a new position in Neuronetics (STIM) in Q2 2026: 470 shares worth $723. The stake represents ﹤0.01% of the portfolio and ranks #832 among its holdings.

87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Allied Private Wealth held 470 shares of Neuronetics worth $723 as of Q2 2026.
  • Neuronetics was a new Allied Private Wealth position in Q2 2026.
  • Neuronetics made up ﹤0.01% of Allied Private Wealth's portfolio in Q2 2026, its #832 holding.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Allied Private Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.